Youhna M.Y.M.AyalaYouhna M.Y.M. i inni, Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function, „Journal of Molecular Biology”, 348 (3), 2005, s. 575–588, DOI: 10.1016/j.jmb.2005.02.038, ISSN0022-2836, PMID: 15826655 [dostęp 2019-10-26].
E.E.BurattiE.E., F.E.F.E.BaralleF.E.F.E., Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, „Journal of Biological Chemistry”, 276 (39), 2001, s. 36337–36343, DOI: 10.1074/jbc.M104236200, ISSN0021-9258, PMID: 11470789 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F., Lien-SzuL.S.WuLien-SzuL.S., C.-K. JamesC.K.J.ShenC.-K. JamesC.K.J., TDP-43: an emerging new player in neurodegenerative diseases, „Trends in Molecular Medicine”, 14 (11), 2008, s. 479–485, DOI: 10.1016/j.molmed.2008.09.001, ISSN1471-4914, PMID: 18929508 [dostęp 2019-10-26].
Lionel M.L.M.IgazLionel M.L.M. i inni, Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies, „Journal of Biological Chemistry”, 284 (13), 2009, s. 8516–8524, DOI: 10.1074/jbc.M809462200, ISSN0021-9258, PMID: 19164285, PMCID: PMC2659210 [dostęp 2019-10-26].
ClaudiaC.ColombritaClaudiaC. i inni, TDP-43 is recruited to stress granules in conditions of oxidative insult, „Journal of Neurochemistry”, 111 (4), 2009, s. 1051–1061, DOI: 10.1111/j.1471-4159.2009.06383.x, ISSN1471-4159, PMID: 19765185 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F. i inni, TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor, „Journal of Neurochemistry”, 105 (3), 2008, s. 797–806, DOI: 10.1111/j.1471-4159.2007.05190.x, ISSN1471-4159, PMID: 18088371 [dostęp 2019-10-26].
ManuelaM.NeumannManuelaM. i inni, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, „Science”, 314 (5796), 2006, s. 130–133, DOI: 10.1126/science.1134108, ISSN1095-9203, PMID: 17023659 [dostęp 2019-10-26].
MasatoM.HasegawaMasatoM. i inni, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, „Annals of Neurology”, 64 (1), 2008, s. 60–70, DOI: 10.1002/ana.21425, ISSN1531-8249, PMID: 18546284, PMCID: PMC2674108 [dostęp 2019-10-26].
nih.gov
ncbi.nlm.nih.gov
S.H.S.H.OuS.H.S.H. i inni, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, „Journal of Virology”, 69 (6), 1995, s. 3584–3596, ISSN0022-538X, PMID: 7745706, PMCID: PMC189073 [dostęp 2019-10-26].
Youhna M.Y.M.AyalaYouhna M.Y.M. i inni, Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function, „Journal of Molecular Biology”, 348 (3), 2005, s. 575–588, DOI: 10.1016/j.jmb.2005.02.038, ISSN0022-2836, PMID: 15826655 [dostęp 2019-10-26].
E.E.BurattiE.E., F.E.F.E.BaralleF.E.F.E., Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, „Journal of Biological Chemistry”, 276 (39), 2001, s. 36337–36343, DOI: 10.1074/jbc.M104236200, ISSN0021-9258, PMID: 11470789 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F., Lien-SzuL.S.WuLien-SzuL.S., C.-K. JamesC.K.J.ShenC.-K. JamesC.K.J., TDP-43: an emerging new player in neurodegenerative diseases, „Trends in Molecular Medicine”, 14 (11), 2008, s. 479–485, DOI: 10.1016/j.molmed.2008.09.001, ISSN1471-4914, PMID: 18929508 [dostęp 2019-10-26].
Lionel M.L.M.IgazLionel M.L.M. i inni, Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies, „Journal of Biological Chemistry”, 284 (13), 2009, s. 8516–8524, DOI: 10.1074/jbc.M809462200, ISSN0021-9258, PMID: 19164285, PMCID: PMC2659210 [dostęp 2019-10-26].
ClaudiaC.ColombritaClaudiaC. i inni, TDP-43 is recruited to stress granules in conditions of oxidative insult, „Journal of Neurochemistry”, 111 (4), 2009, s. 1051–1061, DOI: 10.1111/j.1471-4159.2009.06383.x, ISSN1471-4159, PMID: 19765185 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F. i inni, TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor, „Journal of Neurochemistry”, 105 (3), 2008, s. 797–806, DOI: 10.1111/j.1471-4159.2007.05190.x, ISSN1471-4159, PMID: 18088371 [dostęp 2019-10-26].
ManuelaM.NeumannManuelaM. i inni, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, „Science”, 314 (5796), 2006, s. 130–133, DOI: 10.1126/science.1134108, ISSN1095-9203, PMID: 17023659 [dostęp 2019-10-26].
MasatoM.HasegawaMasatoM. i inni, Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, „Annals of Neurology”, 64 (1), 2008, s. 60–70, DOI: 10.1002/ana.21425, ISSN1531-8249, PMID: 18546284, PMCID: PMC2674108 [dostęp 2019-10-26].
worldcat.org
S.H.S.H.OuS.H.S.H. i inni, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, „Journal of Virology”, 69 (6), 1995, s. 3584–3596, ISSN0022-538X, PMID: 7745706, PMCID: PMC189073 [dostęp 2019-10-26].
Youhna M.Y.M.AyalaYouhna M.Y.M. i inni, Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function, „Journal of Molecular Biology”, 348 (3), 2005, s. 575–588, DOI: 10.1016/j.jmb.2005.02.038, ISSN0022-2836, PMID: 15826655 [dostęp 2019-10-26].
E.E.BurattiE.E., F.E.F.E.BaralleF.E.F.E., Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9, „Journal of Biological Chemistry”, 276 (39), 2001, s. 36337–36343, DOI: 10.1074/jbc.M104236200, ISSN0021-9258, PMID: 11470789 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F., Lien-SzuL.S.WuLien-SzuL.S., C.-K. JamesC.K.J.ShenC.-K. JamesC.K.J., TDP-43: an emerging new player in neurodegenerative diseases, „Trends in Molecular Medicine”, 14 (11), 2008, s. 479–485, DOI: 10.1016/j.molmed.2008.09.001, ISSN1471-4914, PMID: 18929508 [dostęp 2019-10-26].
Lionel M.L.M.IgazLionel M.L.M. i inni, Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies, „Journal of Biological Chemistry”, 284 (13), 2009, s. 8516–8524, DOI: 10.1074/jbc.M809462200, ISSN0021-9258, PMID: 19164285, PMCID: PMC2659210 [dostęp 2019-10-26].
ClaudiaC.ColombritaClaudiaC. i inni, TDP-43 is recruited to stress granules in conditions of oxidative insult, „Journal of Neurochemistry”, 111 (4), 2009, s. 1051–1061, DOI: 10.1111/j.1471-4159.2009.06383.x, ISSN1471-4159, PMID: 19765185 [dostęp 2019-10-26].
I.-FanI.F.WangI.-FanI.F. i inni, TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor, „Journal of Neurochemistry”, 105 (3), 2008, s. 797–806, DOI: 10.1111/j.1471-4159.2007.05190.x, ISSN1471-4159, PMID: 18088371 [dostęp 2019-10-26].
ManuelaM.NeumannManuelaM. i inni, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, „Science”, 314 (5796), 2006, s. 130–133, DOI: 10.1126/science.1134108, ISSN1095-9203, PMID: 17023659 [dostęp 2019-10-26].